CurveBeam AI Ltd.ASX: CVB

Receives first PO for 4 HiRise systems post NMPA Clearance

· Issued by CurveBeam AI Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

CurveBeam AI Ltd. has announced the receipt of its first purchase order for four HiRise systems in China, following NMPA clearance. This order marks a significant step in the company's strategy to commercialize HiRise in the Chinese market through its partnership with Weiying/Wego Orthopedics. The company aims to establish HiRise as a leading weight-bearing CT imaging platform for orthopedic clinicians in China. CEO Greg Brown emphasized the importance of this order in progressing their partnership and commercial execution in the region.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT ASX: CVB 19 November 2026 TM CurveBeam AI receives order for first four HiRise systems in China Highlights • The first order in China, for four HiRise™ weight-bearing CT (WBCT) systems, received from CurveBeam AI’s China partner Weiying/Wego Orthopedics, following NMPA...

CurveBeam AI Ltd. on 6ix

In the deck

Story so far

Earlier from CurveBeam AI

Later from CurveBeam AI

All CurveBeam AI news releases